Status:
UNKNOWN
Trichloroacetic Acid (TCA) Combined With Microdermabrasion in Treatment of Melasma
Lead Sponsor:
Assiut University
Conditions:
Melasma
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
1. To detect the efficacy and safety of combined TCA and MDA in treating melasma. 2. To compare the efficacy and safety of using different TCA concentrations (15% \& 20%) alone and in combination with...
Detailed Description
Melasma is a common, acquired hypermelanosis that occurs in sun exposed areas, mostly on the face, occasionally on the neck, and rarely on the forearms. Melasma is generally a clinical diagnosis cons...
Eligibility Criteria
Inclusion
- Adults of 18 years and above with bilateral melasma
- Clinical diagnosis of melasma.
- Mental capacity to give informed consent.
Exclusion
- Pregnant or nursing women
- Current use of hormonal birth control medication or any hormonal therapy
- History of laser or dermabrasion to the face within 9 months of study enrollment
- Patients with poor wound healing, recurrent herpes simplex and current skin infection (facial warts, molluscum contagiosum) and history of hypertropic scar/keloids
- Photosensitivity.
- Patients with unrealistic expectations All the included patients will be subjected to detailed history taking,dermatological examination and Wood's light examination to estimate the depth (epidermal, dermal or mixed) of melasma.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04823520
Start Date
April 1 2021
End Date
September 30 2022
Last Update
March 30 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.